In November 2026, San Francisco-based voice artificial intelligence developer Ellipsis Health completed the acquisition of New York-based care navigation startup Kouper Health for an undisclosed valuation. The transaction represents an operational transition within digital health: the migration of conversational voice AI from standalone acoustic observation into closed-loop, deterministic execution across clinical workflows.

The European HealthTech and MedTech ecosystem has seen notable moves across clinical AI deployment, funding, and major ecosystem gatherings: Several major developments have emerged across the European Health AI ecosystem this week, spanning new early-stage funding, clinical AI validation, market consolidation analysis, and regulatory policy milestones:

Fertifa, the London healthtech run by venture capitalist Eileen Burbidge, has agreed to buy Tuune, a women's health company whose regulated clinical software helps clinicians deliver personalised hormonal care. The deal, first reported by Sky News, is expected to be announced this week. Its value is not being disclosed.

Every European health fund raised between 2019 and 2022 now holds companies that are alive, off plan and unlikely to raise another priced round. They are not the winners that will return the fund, and they are not the write-offs that have already been taken. They sit in the middle: a CE-marked device with slow hospital uptake, a digital therapeutic with a reimbursement code in one country and nothing elsewhere, a health AI company whose models are good but whose NHS or German

Nelson Advisors has spent 2026 doing two things at once: closing lower-mid-market healthtech deals and telling the rest of the market what it sees. The London-based firm, co-founded by partners Lloyd Price and Paul Hemings, specialises in mergers, acquisitions, partnerships and investments for HealthTech, MedTech, Digital Health, Health IT and Health AI companies with enterprise values between roughly $25 million and $250 million.

KPMG’s 2026 healthcare technology report, based on interviews with 128 senior healthcare technology executives at organisations with revenues above US$1 Billion, finds a sector investing heavily in digital transformation but still struggling to convert that spend into measurable value. KPMG describes organisations as sitting in one of three modes: stabilising core platforms and data integrity, synchronising systems and governance, or scaling AI across workflows at enterprise

Nelson Advisors: Heidi Health, Best Practice and the challenge facing clinical AI is not accuracy of ML models, but access to data infrastructure and integration permissions within established systems. The primary care health technology landscape is undergoing a structural transition from assistive ambient transcription utilities to autonomous, agentic artificial intelligence systems. For several years, ambient voice technology (AVT) operated as a non-invasive layer at the cl